Pharmaceuticals

Pertussis Vaccine Market Outlook Highlighting Key Drivers And Market Evolution

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Pertussis Vaccine Market During The Forecast Period?

The pertussis vaccine market size has consistently expanded in recent years. It is projected to increase from $5.65 billion in 2025 to $5.82 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 2.9%. The market’s expansion historically stems from high childhood immunization coverage, government-driven national vaccination programs, past outbreaks of whooping cough, the integration of the pertussis vaccine into routine immunization schedules, and the availability of whole-cell vaccines.

The pertussis vaccine market is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach $6.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.1%. Factors contributing to this growth during the projected timeframe include heightened awareness regarding adult pertussis immunization, a rise in recommendations for maternal vaccination, progress in enhancing vaccine safety and effectiveness, broader access to healthcare within developing nations, and an increase in the development of combination vaccines. Key trends anticipated for the forecast period encompass the increasing embrace of acellular pertussis vaccines, a heightened emphasis on booster immunization efforts, the broadening availability of combination vaccines containing pertussis, an increase in adult and maternal pertussis vaccinations, and the reinforcement of governmental immunization campaigns.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Drivers Are Supporting The Pertussis Vaccine Market Growth?

Increasing childbirth rates are propelling the expansion of the pertussis vaccine market. Childbirth refers to the process of giving birth to a child, marking the conclusion of pregnancy where the fetus develops within the mother’s uterus, and the start of a new life outside the womb. The pertussis vaccine is predominantly administered to children, offering protection against whooping cough and other severe, potentially life-threatening diseases. For example, a report published in January 2023 by the Centers for Disease Control and Prevention, a US-based national public health organization, revealed that the United States saw a 1% increase in registered births, reaching a total of 3,664,292, when compared to 2022. This upward trend in childbirth rates is therefore a key driver for the growth of the pertussis vaccine market.

How Is The Pertussis Vaccine Market Categorized Across Its Segment Groups?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Which Trends Are Shaping Growth In The Pertussis Vaccine Market?

Leading companies operating within the pertussis vaccine market are concentrating on developing advanced immunization solutions and obtaining regulatory clearances to bolster maternal and infant protection against whooping cough. These efforts aim to enhance vaccine accessibility, broaden its recommended application during pregnancy, and diminish illness associated with pertussis among newborns. For instance, in January 2023, Sanofi S.A., a France-based biopharmaceutical company, received U.S. FDA approval for the expanded use of its Adacel (Tdap) vaccine during the third trimester of pregnancy, enabling maternal immunization to help protect infants younger than two months who are at highest risk of severe pertussis infection. This authorization empowers healthcare professionals to actively immunize pregnant individuals, thereby ensuring that protective antibodies are transferred to the newborn prior to delivery. Consequently, infants acquire early-life immunity against pertussis, bridging the immunity gap until they are eligible for their own immunizations.

Which Firms Are Influencing Competition In The Pertussis Vaccine Market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, CSL Limited, Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

Get The Full Pertussis Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Region Is The Top Contributor To The Pertussis Vaccine Market By Share?

North America was the largest region in the pertussis vaccine market in 2025. The regions covered in the pertussis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pertussis Vaccine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Browse Through More Reports Similar to the Global Pertussis Vaccine Market 2026, By The Business Research Company

Pertussis Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795